Aspen University. E. Zapotek, MD: "Buy online Oxytrol - Discount Oxytrol OTC".
Chemical Gastropathy (Reactive Gastropathy) A number of different agents can produce gastric mucosal injury buy discount oxytrol 2.5 mg line medicine definition, characterized at endoscopy by hemorrhagic lesions and erosions (necrosis to the level of the muscularis mucosa) or ulcers (necrosis extending deeper than the muscularis mucosa) purchase 5mg oxytrol fast delivery treatment 4 stomach virus. Portal hyper- tension produces a congestive gastropathy buy online oxytrol medicine 0025-7974, with vascular ectasia but, again, only a minimal inflammatory infiltrate. Crohn disease of the stomach is uncommon, particularly in the absence of disease elsewhere in the gastrointestinal tract. Endoscopy may show mucosal reddening and nodules with or without overlying erosions and ulcers that may be elongated or serpiginous. Histological features include non-caseating granu- lomata, ulceration, chronic inflammation and submucosal fibrosis. Sarcoidosis of the stomach can be difficult to distinguish endoscopically and histologically from Crohn disease and the diagnosis must be based on the presence of other systemic features. Gastritis with Specific Diagnostic Features Collagenous gastritis has been reported in association with collagenous colitis and lymphocytic colitis; it is very rare. At endoscopy, non-specific findings include mucosal hemorrhages, erosions and nodularity while histology shows a chronic gastritis (plasma cells and intra-epithelial lymphocytes), focal atrophy and focal collagen deposition (2075 m) in the lamina propria. Histology shows an infiltrate of the lamina propria in the antrum or body by plasma cells, lymphocytes and rare neutrophils, and a marked intraepithelial infiltrate with T lymphocytes. Eosinophilic gastritis is associated with peripheral eosinophilia and eosinophilic infiltration of the stomach, involving one or more layers of the gastrointestinal tract (mucosa, muscle or subserosa). Hypertrophic Gastropathies There are numerous causes of thickened gastric folds seen on endoscopy or diagnostic imaging (Table 2). Mntriers disease is associated with protein- losing gastropathy and hypochlorhydria whereas hyperplastic, hypersecretory gastropathy is associated with increased or normal acid secretion and hyper- plasia of the parietal and chief cells, with or without protein loss. Endoscopy, in both cases, typically shows irregular hypertrophic folds involving the body of the stomach, although there is a polypoid variant that resembles multiple hyperplastic gastric polyps. The characteristic histological features are foveolar hyperplasia with cystic dilation; inflammatory infiltrates may be present, as in hypertrophic lymphocytic gastritis, but this is variable. Gastric resection for refractory protein loss, hemorrhage or obstruction is a last resort. Miscellaneous Gastritides Gastritis cystica profunda is a rare sequela of partial gastrectomy with gastro- jejunostomy but it may also develop in the absence of prior gastric surgery. Endoscopy typically shows multiple exophytic gastric masses, which on sec- tion reveal multiple cysts. At histology, foveolar hyperplasia is accompanied by cystic glands that extend through the muscularis mucosae into the submucosa and muscularis propria. It may be associated with chronic atrophic gastritis, hyperplasia or primary gastric stump cancer after surgery. Gastric Polyps and Gastric Malignancy There are numerous types of gastric polyps (Table 4) which are usually incidental findings with little risk of developing into cancer. Gastric polyps are gastric epithelial or non- epithelial protrusions observed either endoscopically or radiologically. The non-epithelial polyps arise from the mesenchymal tissue of the submucosa (such as a leiomyoma). The epithelial polyps are most common, and are often multiple, hyperplastic polyps. Infre- quently, adenomatous or villoadenomatous polyps, which are often singular, occur. Individuals with a parent or sibling with gastric cancer are three times as likely to develop gastric cancer as the general population. Although regular screening is not warranted in either case, minor symptoms should be promptly and thoroughly investigated. In Canada there were 2,800 new gastric cancer cases in 2001 (8 per 100,000) and 1,950 deaths. There are numerous risk factors associated with the development of gastric adenocarcinoma (Table 5). The incidence of gastric adenocarcinoma has been falling dramatically in North America from ~ 30 per 100,000 in the 1930s to 68 per 100,000 at present. There is a disparity in adenocarcinoma incidence between first- and second-generation immigrants, suggesting both genetic and lifestyle or environmental factors together contribute to the risk for cancer. Genetic factors that increase the risk include low gastric acid secretory status and the presence of pro-inflammatory genes such as interleukin-1, which is associated with gastric acid hyposecretion. Several lifestyle factors including diet and smoking increase the risk of gastric cancer but these are potentially modifi- able. Shaffer 155 Polypoid Gastric Size Endoscopic Pathological Comments lesion location appearance features Pancreatic Antrum, 0. Sleisenger & Fordtrans Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management 2006: pg 1149. Environmental Risk Factors Dietary factors that contribute to gastric cancer include a high dietary salt and nitrate/nitrite intake, low fruit and vegetable intake, and the use of tobacco. Persons with the highest intake of vegetables have a significantly reduced risk of gastric cancer compared to those who consume no vegetables. Similar but weaker protective effects have also been observed for consumption of green and cruciferous vegetables. Current smoking adversely influences the risk for gastric cancer, and this risk increases with the intensity and duration of cigarette smoking. Carcinoma of the gastric cardia First Principles of Gastroenterology and Hepatology A. Nested case-control studies showed an increase in the risk of cancer (odds ratios 2. Shaffer 158 higher risk for gastric cancer than older patients, presumably because of their having a longer duration of exposure. In a proportion of patients with chronic atrophic gastritis, intestinal metaplasia develops and, in a much smaller proportion, dysplasia and subsequently cancer (Table 5). Recent studies have shown the importance of inflammation, arising from the initial H. Patients with the interleukin-1 gene cluster polymorphism, which may enhance production of the proinflammatory cytokine interleukin-13, are at increased risk of H. Thus, host genetic factors that affect interleukin- 1 production and hypochlorhydria may influence gastric cancer risk in those infected with H. Such exciting advances in the genetics of gastric cancer promise a means to identify early those who are at risk of this serious malignancy. Secretory products and clinical characteristics of foregut, midgut and hindgut carcinoids (neuroendocrine tumors). Confirmatory diagnosis is usually made at endoscopy when biopsies and the intraluminal extent can be determined. Routine barium meal is of little value in diagnosis although the tumour will often be seen.
National glucose-lowering treatment com- atorvastatin in 2 cheap oxytrol 2.5mg on line medications you should not take before surgery,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac plexity Is greater in nursing home residents than community-dwelling adults buy oxytrol 2.5 mg with amex cancer treatment 60 minutes. Effects of combination lipid residents with non-insulin-dependent diabetes mellitus purchase oxytrol with american express medications causing thrombocytopenia. The use of a no-concentrated-sweets diet with type 2 diabetes mellitus: The Fenobrate Intervention and Event Low- in the management of type 2 diabetes in nursing homes. Successful use of a sucrose-containing erectile function in elderly patients with erectile dysfunction: A subgroup enteral formula in diabetic nursing home elderly. Lispro insulin treatment in comparison with regular human insulin tes: A multicenter double-blind placebo-controlled xed-dose study. Type 1 and type 2 diabetes and incident hip frac- nursing home patients with tight glycaemic control. Can J Diabetes 42 (2018) S296S306 Contents lists available at ScienceDirect Canadian Journal of Diabetes journal homepage: www. Screening for diabetes should Acknowledge the legacy of colonization and its ongoing adverse effects on be carried out earlier and at more frequent intervals. This legacy: Effective prevention strategies are essential and should be grounded in the Maintains socioeconomic disadvantage that limits healthy choices (diet, specic social, cultural and health service contexts of the community. Early identication of diabe- Stirs experiences of shame and stigma with a diagnosis of tes in pregnancy is important, and postpartum screening for diabetes in diabetes; women with a history of gestational diabetes should be performed along May recall residential school-like conditions with health-care pro- with appropriate follow up. A focus on building a therapeutic rela- In clinical interactions, recognize, explore and acknowledge: tionship with an Indigenous person with diabetes is important rather than Discord within the therapeutic relationship that may arise from height- a singular emphasis on achieving management targets. The current poor ened apprehension by the Indigenous person with diabetes as well success at achieving management targets highlights the limitations of health as emotional reaction to prejudice, power and authority asserted by services when they are not relevant to the social and cultural contexts of health-care providers; Indigenous peoples. If you are in a community with high rates of diabetes, nity levels that advocate for family and community resources for see a health-care provider to learn about ways to be tested for and prevent Indigenous peoples; diabetes. In par- ticular, seek to understand the relationships between the history of colo- Note: In this document, the terms Aboriginal and Indigenous are generally nization and the current high rates of diabetes in Indigenous peoples. In the Canadian context, there are 3 Aboriginal groups rec- ens and gardens, and school-based activities for children and teenagers. It is important If you are planning a pregnancy or may get pregnant, get screened for dia- to recognize that while many Indigenous peoples live in their original land- betes. Diabetes within the Indigenous population is complex rates of adverse outcomes of diabetes in pregnancy, including mac- and socially mediated (1,2). Elucidating Diabetes in Indigenous populations globally is linked to a complex the vital relational and culturally informed aspects of care that might array of factors; however, a common thread is the shared history enable the facilitation of improved diabetes outcomes requires focus- of colonization (35). As connection to a traditional world nized colonization as the most signicant social determinant of view and way of life can be protective, it is important for health- health affecting Indigenous peoples worldwide (35). In Canada, this care providers to be able to appropriately elicit and support Indig- involved: the outlawing of Indigenous gatherings and ceremonies enous peoples with diabetes who may want to (re)engage in cultural at the end of the nineteenth and throughout the rst half of the practices (4,5). All have made 94 calls to action related to many domains of public life, undermined Indigenous cultures and values, leading to lasting and including health (6). It is also essential to realize that the impacts in the current health status of Indigenous peoples. In Canada, age- type 2 diabetes with abnormal postprandial glucose and normal standardized prevalence rates for diabetes are 17. A recent study in Alberta experiences and subsequent incidence of type 2 diabetes (53,54). Among the Inuit people, the age- rience, which hinders access to needed resources (e. The rising incidence among youth and young adults cessed foods to be associated with incident diabetes, whereas (12,16,17) has been shown to be accompanied by 2. Improving health outcomes would involve ensuring health Retinal photography screening has also been utilized in Canada service quality and equity tailored to the needs of Indigenous peoples in remote areas (75), and has been shown to increase the number with diabetes. This means addressing the social origins of disease of screened individuals in Australia (76) (see Retinopathy chapter, and illness located within Indigenous contexts of colonization, ineq- p. New approaches to care are needed that are cul- 89,552 participants in 49 states, 4. While individuals may benet from the diagnosis and treatment of depres- sion and other mental health illnesses, cultural approaches may be Screening in Indigenous Peoples and/or Communities more appropriate (4,5). Furthermore, several studies have demon- strated associations between greater cultural continuity and better Screening and prevention strategies should be implemented in mental health outcomes. Local traditional approaches to wellness collaboration with community leaders, Indigenous peoples with dia- around management and support for depression should be explored betes, health-care professionals, and funding agencies to engage when appropriate. Such partnerships are important for prioritizing and with an A1C test at the rst antenatal visit to identify pre-existing incorporating local social and cultural contexts, building both trust- diabetes (78). S255), the rationale for screening remains strong, and follow-up is also encouraged in individuals with prediabetes particularly to detect previously undiagnosed type 2 diabetes. In addition, all women not previously screened for dia- 1 risk factor (high-risk ethnic group), screening for type 2 diabe- betes should be tested between 24 to 28 weeks of gestation. The Diabetes Prevention Program from the United States is not recommended, it should be noted that it has often hap- was effective for all ethnicities, but the extent to which it can be pened and continues to happen in community contexts. Primary pre- tial that this type of screening be conrmed in a health-care setting. Community involvement in developing the interven- were carried out in Kahnawake and Sandy Lake, where broad tion and framing the intervention within Indigenous cultural community-based participatory research projects were con- perspectives have been variable. Although unpublished, Drop the Pop campaigns A study with Algonquin women sought to understand the have taken hold in various communities. Tribal schools also are providing hands-on adapted to needs and culture; the possibility of saving money learning activities about growing healthy foods. More recently, Finally, pregnancy provides an optimal window of opportunity a prevention study in 3,135 participants in 36 Indigenous commu- for intervention to reduce long-term risk for both mothers and off- nities in the United States showed baseline psychosocial charac- spring. Nevertheless, it remains unclear whether increased knowledge and awareness, or increased community physical Management activity resources ll a gap created by structural barriers from social inequities and colonization. Prevention should be critically Similar to prevention strategies, management of diabetes with informed by the social contexts that shape the health of Indig- Indigenous peoples should incorporate the social and cultural con- enous peoples, as well as resourced to ensure effectiveness and texts of the community from which the person originates, while sustainability. For example, the United States-based Traditional Foods also adhering to current clinical practice guidelines (66). One pilot Project aimed to increase access to traditional foods, physical activ- study with a wait-list control group in Native Hawaiians showed ity and social support (88). Indigenous communities across the that culturally adapted diabetes self-management education build- country applied their traditional ecological knowledge, specic to ing on culturally relevant knowledge and activities (i. A local language, incorporation of local images/food/common physi- collection of stories told by tribes about their traditional foods cal activities/local people to increase relevance) for 3 months systems was published on the Native Diabetes Wellness Program improved A1C, diabetes understanding and diabetes self- website. In a qualitative study in rural Australia, par- sustainability, embedded in cultural signicance and emotional ticipants reported both negative inuences (i.
Service providers who only transport and store a therapy device need only apply for authorization for possession and transport of the radioactive material oxytrol 2.5mg low price medications not to take before surgery. In this case purchase oxytrol with visa medications related to the integumentary system, when the service provider is only transporting the therapy device for use buy 2.5mg oxytrol visa treatment 4 syphilis, the client must possess a license for medical use of the radioactive material. Additionally, in this case, the client is authorized to provide the patient treatments and is responsible for all aspects of the radioactive material use and patient treatments upon transfer of the radioactive material to their possession. Licensed activities must be conducted in accordance with the regulations for compliance with 4731. The letter will permit the use of radioactive material at the clients address and will clearly delineate the authority and responsibility of each entity. This agreement must be applicable for the entire period of time over which the service is to be provided. Additionally, the licensee must survey to ensure compliance with the requirements in 4731. One type of location is the base location where licensed material is received, stored, and sometimes used. The following two sections describe the type of information necessary for base locations and temporary job sites. The base facility may be located in a medical institution, non-institutional medical practice, commercial facility, or mobile van. Applicants should specify in what type of facility the proposed base facility is located. A mobile licensee cannot provide a service to a non-licensed private practice located within a licensed medical institution (e. Applicants must submit a description and diagram(s) of the proposed base facility and associated equipment. The description and diagram of the proposed facility should demonstrate that the building (or van) is of adequate construction and design to protect its contents from the elements (e. For storage locations within a van, the description of the van should address radiation levels in the van drivers compartment to demonstrate compliance with 4731. Radioactive material must be delivered only to a facility licensed to receive the type of radioactive material ordered. When the base facility is in the van, and there is no permanent structure for the radioactive material storage, provide for the following: o Secured off-street parking under licensee control. It is essential that the mobile medical service have access to the facility in the event of contamination. Documentation from both parties will illustrate the agreement between the client and the mobile medical service. Client Site This section applies only to therapeutic uses of radioactive material. For all types of therapy uses, the medical institutions, hospitals, or clinics and their addresses that comprise the client sites for mobile medical services must be listed. The system must provide sufficient light to perform any possible emergency procedures, including the removal of a detached or stuck source that remains within the patient. If transportable services to the clients site for use within the clients facility by the mobile medical services employees will be provided, applicants should provide the following client facility information and commitment: A detailed description and diagram(s) of the proposed use facility (e. The description and diagram of the proposed use facility must demonstrate that the facility is of adequate construction and design to protect its contents from the elements (e. Applicants should include a diagram showing the location of the equipment, receipt, and use areas, and identify all areas adjacent to restricted areas. For a transport-only mobile medical service for therapy devices that are transported to the clients facility, used by the clients staff (under their own license), and removed by the service provider, applicants must ensure the following: Each client is properly licensed for medical use of radioactive material. If applicable, applicants should ensure that each client has received the necessary initial and, if appropriate, recurrent training for the specific make and model of the remote afterloader device being provided. If the above applicable conditions are not met, the mobile medical service licensee must not transfer the remote afterloader device to the client. This includes such activities as dosage measurements, source calibrations, and remote afterloader device operational checks. Although these and other services may be provided to the client by the mobile medical service if the mobile medical service is specifically licensed to provide such services, the client (licensee) retains all of the responsibilities related to the use of the radioactive material for patient treatments. The responsibilities for supervising individuals who use the radioactive material, set forth in 4731. A signed receipt of each transfer must be made and retained for inspection for three years. Training for Individuals Working In or Frequenting Restricted Areas Drivers and technologists (or therapists) will be properly trained in applicable transportation regulations and emergency procedures in addition to the applicable training requirements of 4731. Survey Instrument and Dose Measurement Instrument Checks Instruments must be checked for proper operation before use at each address of use. Dosage measurement instruments must be checked before medical use at each address of use or on each day of use, whichever is more frequent. Order and Receipt of Radioactive Material Radioactive material must be delivered by a supplier to the base location or to the clients address if the client is licensed to receive the type of radioactive material ordered. Delivery of radioactive material to a van that is not occupied by the mobile medical service personnel will not be permitted. The transportation emergency response plan should cover both the actions to be taken by the mobile medical service providers headquarters emergency response personnel and the on-scene hazardous material-trained personnel, and it will be readily available to both transport vehicle personnel and headquarters emergency-response contacts. If any problem is found, including remote afterloader device interlocks and operation, the remote afterloader device or facility will be repaired and recertified by the device vendor prior to return to service. The response may range from phone contact for minor spills to prompt on-site response (less than 3 hours) to events such as a medical event or lost radioactive material. Radioactive Waste Management If waste will be stored in vans, the vans will be properly secured and posted as radioactive material storage locations. Applicants will ensure that the van will be secured against unauthorized access and that the waste storage location will be posted as a radioactive material storage area. Excreta from individuals undergoing medical diagnosis or therapy with radioactive material may be disposed of without regard to radioactivity if it is discharged into the sanitary sewerage system, in accordance with 4731. However, collecting excreta from patients in a van restroom with a holding tank is not considered direct disposal into the sanitary sewerage system. Mobile Medical Services with Remote Afterloader Devices Because the movement of the remote afterloader device from one location to another increases the risk of electro-mechanical component failures or misalignments, it is important that the proper operation of the device be fully checked after each such relocation. Therefore, applicants will develop, document, and implement the following procedures to determine if a device is operating properly before the commencement of patient treatments: Safety checks conducted on a remote afterloader device and facility. Additionally, the procedure should include provisions for prompt repair of any system not operating properly. These surveys should include the source housing with the source in the shielded position and all areas adjacent to the treatment room with the source in the treatment position. State on your application, "We have developed a procedure for ordering and receiving radioactive material that is appended as Appendix I," and submit your procedure. The material and quantity must also be approved for the requesting authorized user. Packages should be placed on a cart or wheelchair and taken immediately to the Nuclear Medicine Department, Room. If the package appears damaged or leaking, you should immediately contact one of the individuals identified below.
Cheap oxytrol 2.5mg. Dr.Baswanandam live in hmtv about gastritis and HIV treatment on 3-11-2019.
The following two pair-wise comparisons were made: 1) Sildenafil 25 mg versus sildenafil 50 mg 2) Sildenafil 50 mg versus sildenafil 100 mg The efficacy and harm outcomes examined in the meta-analysis (i order cheap oxytrol medications just like thorazine. Assessment of Publication Bias Funnel plots were generated to assess the extent of asymmetry for each meta-analysis cheap oxytrol uk symptoms knee sprain. The following list shows the reference identifications for these trials and corresponding publications (each row) cost of oxytrol treatment centers in mn. The total and mean numbers of patients randomly assigned to an intervention or placebo across the 22 trials were 8,621 and 392, 193 respectively, while the number of randomly assigned patients in each trial ranged from 21 to 190 1020. In one trial patients 203 were instructed to take the dose 8 hours before sexual activity for up to one dose a day. The Jadad total 206 191,197 score for the individual trials ranged from one to five. The methods for generating the 183,191,192,197 sequence of random assignment were described for four studies and were judged to 206 be appropriate. For all trials except 189 for one the methods for treatment allocation concealment were judged to be unclear. This section presents results derived from 21 placebo-controlled trials that compared the efficacy and harms profile of 180-184,189,191-201,203-206 190 vardenafil (any dose) to that of placebo. One trial that explored a dose- response effect of vardenafil, without using a placebo arm, is reviewed in a later section (vardenafil dose 1 versus vardenafil dose 2). The proportions of patients with one or more adverse event in vardenafil groups across the trials ranged from 182 189 about 27 percent (10 mg dose) to 74 percent (20 mg dose). The corresponding proportion 200 189 for the placebo groups ranged from about 17 percent to 52 percent. Two of the 20 trials did not report the proportion of withdrawals due to adverse events. The corresponding 193,195,203 189 rate for the placebo-treated patients ranged from 0 percent to 6 percent. The absence or occurrence of serious adverse events could not be 189,199,206 ascertained for three trials. In general, judging from the results of these trials, there were no obvious numerical or statistical differences in the occurrence of serious adverse events between patients randomly assigned to receive vardenafil and those assigned to placebo. None of the trials were designed to compare flexible and fixed dosage regimens of vardenafil. The similar trend was observed in a trial that compared 20 mg and 40 mg doses of vardenafil (47. The most frequently observed adverse events in the 10 trials were 190 headache, flushing, dyspepsia, or rhinitis. In one trial, eight and 13 patients developed visual 189 disturbance(s) in the 10 mg and 20 mg groups, respectively. In another trial, two patients (one patient in each 5 mg and 20 mg groups) were observed to have visual disturbances (sensory, abnormal vision, and brightening). There was no apparent numerical or statistically significant difference in the occurrence of serious adverse events across the treatment arms of various doses of vardenafil. In another study, the corresponding proportions of patients with at least one serious adverse event were 5, 3, 192 190 and 4 percent. Results from two other trials demonstrated trends of a numerical increase in the rate of improved erections across 5 mg, 10 mg, and 20 mg doses of vardenafil. The highest proportion of patients with improved erections was observed in the 20 189,192 181 mg groups (range 80. In another trial, the proportion of participants with 49 improved erections was higher in participants who received 20 mg compared with those who received 10 mg of vardenafil (72 versus 57 percent, p < 0. The analyses presented in this section did not include 10 trials for the following reasons: distinct clinical groups of patients (e. One of the 184 trials was restricted to patients who were nonresponders to previous treatment with sildenafil. Only three trials including diabetic patients were potentially suitable for meta-analysis. Meta-analyses for efficacy outcomes in diabetes patients were not performed in view of missing qualitative or quantitative information (i. This meta-analysis included results from three 181,204,205 trials of patients with diabetes. The analysis in this section 181,183,205 193,195 excluded trials of distinct clinical groups of patients and crossover trials. The occurrence of serious adverse events could not be 189,194 ascertained for two trials. Assessment of Publication Bias Funnel plots were generated and examined to graphically assess the extent of asymmetry (i. Of the two Italian trials, one was funded by Pfizer; the other did not report the funding source. Further information on trial characteristics is provided in Table F-3 (Appendix F). The total and mean numbers of patients randomly assigned to study interventions or placebo across the 30 trials were 10,718 and 358, 232 respectively. The number of patients randomly assigned across the trials ranged from 20 to 214 4,262. One trial additionally excluded patients 233 with prostate-specific antigen levels >10 ng/mL. The approximate proportion of Caucasians in the remaining 17 trials ranged from 73 224 163,220 218, percent to 100 percent. Interventions Patients across the 30 trials that were reviewed received oral tadalafil monotherapy in either 215,221,226 experimental or active control arms. One trial included three additional 238 randomized arms in which patients received 2 mg, 5 mg or 25 mg of tadalafil. In another trial, one additional arm of randomly assigned patients received 5 mg of tadalafil. In one placebo- 235 controlled trial, patients were randomly assigned to receive either 2. Outcomes In total, all 30 trials reported some information on the absence and/or occurrence of either total or serious adverse events. The number of patients who withdrew as a 221,232 result of adverse events was reported in all but two trials. Study Quality and Reporting The mean Jadad total score for the 30 included trials was 3. Three trials could not have been double blinded because patients received either 214,228,232 on-demand or fixed dosing regimens of tadalafil. Only 219,238,239 three trials reported some information on the allocation concealment, which was deemed to be adequate. The adequacy of allocation concealment for the remaining 27 trials could not be ascertained (i. The length of washout period 118 121,228,232 for the seven remaining crossover trials ranged from 4 days to 14 days.
